CTI BIOPHARMA CORP Quarterly Costs and Expenses in USD from Q2 2010 to Q1 2023

Taxonomy & unit
us-gaap: USD
Description
Total costs of sales and operating expenses for the period.
Summary
Cti Biopharma Corp quarterly/annual Costs and Expenses history and growth rate from Q2 2010 to Q1 2023.
  • Cti Biopharma Corp Costs and Expenses for the quarter ending March 31, 2023 was $33.3M, a 10.8% decline year-over-year.
  • Cti Biopharma Corp Costs and Expenses for the twelve months ending March 31, 2023 was $130M, a 12.1% increase year-over-year.
  • Cti Biopharma Corp annual Costs and Expenses for 2022 was $134M, a 40.3% increase from 2021.
  • Cti Biopharma Corp annual Costs and Expenses for 2021 was $95.3M, a 99.6% increase from 2020.
  • Cti Biopharma Corp annual Costs and Expenses for 2020 was $47.8M, a 8.43% increase from 2019.
Costs and Expenses, Trailing 12 Months (USD)
Costs and Expenses, Quarterly (USD)
Costs and Expenses, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2023 $130M $33.3M -$4.05M -10.8% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-15
Q4 2022 $134M $34.7M -$696K -1.97% Oct 1, 2022 Dec 31, 2022 10-K 2023-03-06
Q3 2022 $134M $30.5M +$7.08M +30.3% Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-07
Q2 2022 $127M $31.2M +$11.7M +60% Apr 1, 2022 Jun 30, 2022 10-Q 2022-08-08
Q1 2022 $116M $37.4M +$20.3M +119% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 $95.3M $35.4M +$20.6M +139% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-06
Q3 2021 $74.8M $23.4M +$12.3M +112% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-07
Q2 2021 $62.4M $19.5M +$9.51M +95.1% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-08
Q1 2021 $52.9M $17.1M +$5.14M +43.1% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q4 2020 $47.8M $14.8M +$5.32M +56.2% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-31
Q3 2020 $42.4M $11M -$955K -7.96% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-12
Q2 2020 $43.4M $10M -$1.41M -12.4% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-05
Q1 2020 $44.8M $11.9M +$759K +6.79% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-06
Q4 2019 $44.1M $9.47M -$4.43M -31.8% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-17
Q3 2019 $48.5M $12M -$3.49M -22.5% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-10
Q2 2019 $52M $11.4M -$3.21M -21.9% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-07
Q1 2019 $55.2M $11.2M -$4.01M -26.4% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-15
Q4 2018 $59.2M $13.9M -$265K -1.87% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-13
Q3 2018 $59.5M $15.5M +$2.02M +15% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-04
Q2 2018 $57.4M $14.6M -$2.34M -13.8% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-01
Q1 2018 $59.8M $15.2M -$4.89M -24.4% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-02
Q4 2017 $64.7M $14.2M -$529K -3.6% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-13
Q3 2017 $65.2M $13.5M -$19.6M -59.3% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-01
Q2 2017 $84.8M $17M -$9.47M -35.8% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-03
Q1 2017 $94.3M $20.1M -$12.3M -37.9% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-03
Q4 2016 $107M $14.7M -$22.8M -60.8% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-07
Q3 2016 $129M $33.1M +$180K +0.55% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-07
Q2 2016 $129M $26.4M -$5.7M -17.7% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-04
Q1 2016 $135M $32.3M +$2.14M +7.07% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-03
Q4 2015 $133M $37.5M -$19.6M -34.4% Oct 1, 2015 Dec 31, 2015 10-K 2018-03-07
Q3 2015 $152M $32.9M +$855K +2.67% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-08
Q2 2015 $152M $32.1M +$4.12M +14.7% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-04
Q1 2015 $147M $30.2M +$1.14M +3.91% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-10
Q4 2014 $146M $57.2M +$34.6M +153% Oct 1, 2014 Dec 31, 2014 10-K 2017-03-02
Q3 2014 $112M $32.1M +$16.2M +102% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-05
Q2 2014 $95.5M $28M +$9.85M +54.3% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-06
Q1 2014 $85.6M $29.1M +$9.43M +48% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-06
Q4 2013 $76.2M $22.6M +$3.7M +19.6% Oct 1, 2013 Dec 31, 2013 10-K 2014-03-04
Q3 2013 $72.5M $15.8M +$698K +4.61% Jul 1, 2013 Sep 30, 2013 10-Q 2014-10-31
Q2 2013 $71.8M $18.2M -$31.2M -63.2% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-04
Q1 2013 $103M $19.6M +$1.55M +8.56% Jan 1, 2013 Mar 31, 2013 10-Q 2014-04-29
Q4 2012 $101M $18.9M +$8.94M +90.2% Oct 1, 2012 Dec 31, 2012 10-K 2014-03-04
Q3 2012 $92.6M $15.1M -$141K -0.92% Jul 1, 2012 Sep 30, 2012 10-K 2014-03-04
Q2 2012 $92.7M $49.4M +$32.5M +192% Apr 1, 2012 Jun 30, 2012 10-K 2014-03-04
Q1 2012 $60.2M $18.1M -$1.97M -9.83% Jan 1, 2012 Mar 31, 2012 10-K 2014-03-04
Q4 2011 $62.2M $9.91M Oct 1, 2011 Dec 31, 2011 10-K 2014-03-04
Q3 2011 $15.3M +$2.3M +17.7% Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-01
Q2 2011 $16.9M -$3.06M -15.3% Apr 1, 2011 Jun 30, 2011 10-Q 2011-07-28
Q1 2011 $20.1M Jan 1, 2011 Mar 31, 2011 10-Q 2012-04-20
Q3 2010 $13M Jul 1, 2010 Sep 30, 2010 10-Q 2011-10-25
Q2 2010 $20M Apr 1, 2010 Jun 30, 2010 10-Q 2011-07-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.